We are international
Donate
• myeloma tv TEXT SIZE   
webcasts from medical meetings    back

Phase II study of total therapy 3 (TT3) with added bortezomib (V) for multiple myeloma.
06.10.07
Bart Barlogie, MD, PhD
Arkansas Cancer Research Center
Little Rock, Arkansas, USA


 related articles